E
Elicera Therapeutics AB
STO:ELIC
Elicera Therapeutics AB
STO:ELIC
Price:
5.59
SEK
-1.58%
Market Closed
Market Cap:
kr271.3m
Balance Sheet
Balance Sheet Decomposition
Elicera Therapeutics AB
Elicera Therapeutics AB
Balance Sheet Decomposition is not available for
Elicera Therapeutics AB
Elicera Therapeutics AB
Balance Sheet
Elicera Therapeutics AB
Elicera Therapeutics AB
Currency: SEK
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
12
|
52
|
44
|
29
|
26
|
25
|
|
| Cash |
12
|
52
|
44
|
29
|
26
|
25
|
|
| Total Receivables |
0
|
0
|
2
|
1
|
1
|
3
|
|
| Other Current Assets |
0
|
2
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
12
|
54
|
46
|
30
|
28
|
27
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
13
N/A
|
55
+335%
|
46
-15%
|
30
-35%
|
28
-9%
|
27
-1%
|
|
| Liabilities | |||||||
| Accounts Payable |
2
|
2
|
1
|
1
|
2
|
3
|
|
| Accrued Liabilities |
0
|
0
|
13
|
12
|
4
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
14
|
14
|
7
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+6%
|
14
+440%
|
14
+2%
|
7
-51%
|
4
-40%
|
|
| Equity | |||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
2
|
|
| Retained Earnings |
2
|
15
|
35
|
51
|
67
|
85
|
|
| Additional Paid In Capital |
12
|
67
|
67
|
62
|
87
|
106
|
|
| Other Equity |
0
|
0
|
0
|
5
|
0
|
0
|
|
| Total Equity |
10
N/A
|
52
+410%
|
33
-37%
|
16
-50%
|
21
+27%
|
23
+12%
|
|
| Total Liabilities & Equity |
13
N/A
|
55
+335%
|
46
-15%
|
30
-35%
|
28
-9%
|
27
-1%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
20
|
20
|
20
|
20
|
35
|
49
|
|
Switch to:
Switch to:
See Also
Discover More
